Format

Send to

Choose Destination
EMBO Rep. 2018 Sep;19(9). pii: e46380. doi: 10.15252/embr.201846380.

Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center